Product image of Optruma (Raloxifene Hydrochloride) supplied by GNH India

Optruma

Active Ingredient:
Raloxifene Hydrochloride
Origin:
EU

Optruma (Raloxifene Hydrochloride)

Raloxifene hydrochloride, the active ingredient in Optruma, is a selective estrogen receptor modulator presented as an oral formulation for oral use. It is indicated for the prevention and treatment of osteoporosis in postmenopausal women and for reducing the risk of invasive breast cancer in high‑risk women.

GNH India supplies Optruma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Eli Lilly Nederland B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Optruma acts on bone metabolism and estrogen‑dependent pathways to address several clinical conditions.
  • Osteoporosis: improves bone mineral density and lowers fracture risk in postmenopausal women.
  • High‑risk breast cancer: decreases the incidence of invasive breast cancer in women with elevated risk.
  • Postmenopausal bone health: helps maintain skeletal strength and reduces bone loss.

How It Works

  • Raloxifene binds to estrogen receptors, acting as an agonist in bone tissue to stimulate osteoblastic activity and inhibit osteoclast-mediated resorption, while antagonizing estrogen effects in breast and uterine tissue, thereby preventing estrogen‑driven proliferation.

Side Effects

Common Side Effects

  • Hot flashes: transient feeling of warmth and sweating.
  • Leg cramps: muscle tightness, often in calves.
  • Nausea: mild gastrointestinal upset.
  • Headache: mild to moderate intensity.
  • Dizziness: sensation of light‑headedness.
  • Swelling: peripheral edema, especially in lower limbs.

Serious or Rare Side Effects

  • Deep vein thrombosis: blood clot formation in deep veins.
  • Pulmonary embolism: blockage of pulmonary arteries.
  • Stroke: cerebrovascular accident.
  • Myocardial infarction: heart attack.
  • Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Hepatic dysfunction: abnormal liver enzymes or jaundice.

Precautions & Warnings

  • Before initiating therapy, clinicians should consider several safety measures.
  • Assess bone density: obtain baseline DEXA scan.
  • Screen for thromboembolic history: avoid if prior clotting events.
  • Monitor lipid profile: periodic cholesterol checks recommended.
  • Avoid use in pregnancy: contraindicated due to unknown fetal risk.
  • Store at ambient temperature: keep in original container, protect from moisture.

Avoid Interactions

Raloxifene may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Estrogen therapy: may diminish raloxifene efficacy.
  • Warfarin: increased risk of thrombotic events.
  • Tamoxifen: antagonistic effect on breast tissue.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma concentrations.
  • CYP3A4 inducers (e.g., rifampin): may lower drug levels.

Frequently Asked Questions

Optruma contains raloxifene hydrochloride and is prescribed to prevent and treat osteoporosis in postmenopausal women and to lower the risk of developing invasive breast cancer in women who are considered high‑risk.

Raloxifene binds to estrogen receptors, acting as an agonist in bone to increase bone density while antagonizing estrogen activity in breast and uterine tissue, thereby reducing estrogen‑driven cell proliferation.

The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s medical condition, age, and other individual factors. Patients should follow the prescriber’s instructions exactly.

Safety of raloxifene in pregnancy and lactation has not been established. It is generally contraindicated in pregnant women, and breastfeeding mothers should discuss alternatives with their healthcare provider.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Optruma belongs to the selective estrogen receptor modulator (SERM) class, offering bone‑protective benefits without the estrogenic effects seen with hormone replacement therapy. Compared with bisphosphonates, it has a different safety profile, notably a lower risk of gastrointestinal irritation but a higher vigilance for thromboembolic events.

Store Optruma at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed.

Optruma is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with a full glass of water; do not crush or chew unless specifically instructed.

The most serious risks include deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. Patients should be alert for symptoms such as leg pain or swelling, sudden shortness of breath, chest pain, or neurological changes and seek immediate medical attention if they occur.

Optruma is contraindicated in women who are pregnant, have a history of thromboembolic disorders, active liver disease, or known hypersensitivity to raloxifene or any of its excipients. It should also be used with caution in patients with cardiovascular risk factors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Raloxifene Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT